Mechanistic analysis of VDR-mediated renin suppression

Nephron - Physiology

Volumn 107, Issue 2, 2007, Pages

  Nakane, Masaki ^a,b   Ma, Junli ^a   Ruan, Xiaoan ^a   Kroeger, Paul E ^a   Wu Wong, Ruth ^a  

^a ABBOTT LABORATORIES   (United States)

^b NONE   (United States)

Author keywords

As4.1 cells; Cyclic AMP responsive element; Expression profiling; Paricalcitol; Renin; Transcription factors; Vitamin D

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CALCITRIOL; CYCLIC AMP; NUCLEAR RECEPTOR COREPRESSOR; PARICALCITOL; RENIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DOWN REGULATION; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ANALYSIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CALCITRIOL; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION PROFILING; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, CALCITRIOL; RENIN; RNA, MESSENGER;

EID: 35048896066     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106792     Document Type: Article

References (31)

1. Brown AJ, Dusso AS, Slatopolsky E: Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant 2002;17:10-19.
2. Carlberg C, Quack M, Herdick M, Bury Y, Polly P, Toell A: Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues. Steroids 2001;66:213-221.
3. Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A, Muhlestein JB: Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol 2003;42:57-63.
4. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-1315.
5. Martin KJ, Gonzalez EA: Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism. Semin Nephrol 2004;24:456-459.
6. Nakai S, Shinzato T, Nagura Y, Masakane I, Kitaoka T, Shinoda T, Yamazaki C, Sakai R, Ohmori H, Morita O, Iseki K, Kikuchi K, Kubo K, Suzuki K, Tabei K, Fushimi K, Miwa N, Wada A, Yanai M, Akiba T: An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial 2004;8:3-32.
7. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-456.
8. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780.
9. Young EW, Albert JM, Akiba T, Greenwood R, Kimata N, W. LN, Piera L, Saran R: Vitamin D therapy and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2005;16:THPO0735.
10. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006;70:1858-1865.
11. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D 3 users in a haemodialysis population. Nephrol Dial Transplant 2004;19:179-184.
12. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
13. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C: VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. Faseb J 2000;14:1455-1463.
14. Dunlop TW, Vaisanen S, Frank C, Carlberg C: The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha, 25(OH)2D3 targets. J Steroid Biochem Mol Biol 2004;89-90:257-260.
15. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW: Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem 1996;271:22499-22505.
16. Zheng W, Li YC: Vitamin D suppression of renin gene expression is mediated by DNA sequences in the proximal renin gene promoter. J Am Soc Nephrol 2004;15:PO946.
17. Shi Q, Black TA, Gross KW, Sigmund CD: Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res 1999;85:479-488.
18. Shi Q, Gross KW, Sigmund CD: Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem 2001;276:3597-3603.
19. Pan L, Black TA, Shi Q, Jones CA, Petrovic N, Loudon J, Kane C, Sigmund CD, Gross KW: Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem 2001;276:45530-45538.
20. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 2002;16:1243-1256.
21. Boonyaratanakornkit V, Melvin V, Prendergast P, Altmann M, Ronfani L, Bianchi ME, Taraseviciene L, Nordeen SK, Allegretto EA, Edwards DP: High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 1998;18:4471-4487.
22. Kakegawa H, Tagami K, Ohba Y, Sumitani K, Kawata T, Katunuma N: Secretion and processing mechanisms of procathepsin L in bone resorption. FEBS Lett 1995;370:78-82.
23. Arbour NC, Darwish HM, DeLuca HF: Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells. Biochim Biophys Acta 1995;1263:147-153.
24. 3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 1996;137:2001-2011.
25. Chen KS, DeLuca HF: Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995;1263:1-9.
26. 3 and parathyroid hormone in AOK-B50 cells. Arch Biochem Biophys 2000;381:323-327.
27. 3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene. J Biol Chem 1996;271:16310-16316.
28. 3 dependency of vitamin D receptor-retinoid X receptor-vitamin D-responsive element complex formation. Arch Biochem Biophys 1997;341:75-80.
29. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;15:5789-5799.
30. 3 receptor: implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem 1998;273:10338-10348.
31. 3 receptor homodimer. J Cell Biochem 1996;60:322-333.